OR3A2 (olfactory receptor family 3 subfamily A member 2)

Gene: OR3A2 (olfactory receptor family 3 subfamily A member 2) Homo sapiens

Analyze

Symbol:

OR3A2

Name:

olfactory receptor family 3 subfamily A member 2

RGD ID:

1350655

HGNC Page

HGNC:8283

Description:

Predicted to enable olfactory receptor activity. Predicted to be involved in signal transduction. Predicted to be located in membrane. Predicted to be active in plasma membrane.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

olfactory receptor 17-228; olfactory receptor 3A2; olfactory receptor OR17-14; olfactory receptor, family 3, subfamily A, member 2; OLFRA04; OR17-14; OR17-228; OR228

RGD Orthologs

Alliance Genes

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	17	3,276,113 - 3,386,308 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	17	3,276,177 - 3,386,317 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	17	3,179,407 - 3,289,602 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	17	3,127,934 - 3,129,018 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	17	3,128,013 - 3,236,337	NCBI
Celera	17	3,194,908 - 3,195,992 (-)	NCBI		Celera
Cytogenetic Map	17	p13.3	NCBI
HuRef	17	3,073,409 - 3,074,493 (-)	NCBI		HuRef
CHM1_1	17	3,190,075 - 3,191,159 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	17	3,164,339 - 3,275,247 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Annotation Click to see Annotation Detail View

Disease Annotations Click to see Annotation Detail View

genetic disease (IAGP)

Gene-Chemical Interaction Annotations Click to see Annotation Detail View

benzo[a]pyrene (EXP)

crocidolite asbestos (EXP)

Gene Ontology Annotations Click to see Annotation Detail View

Biological Process

detection of chemical stimulus involved in sensory perception of smell (IEA)

G protein-coupled receptor signaling pathway (IEA)

sensory perception of chemical stimulus (TAS)

sensory perception of smell (IEA)

signal transduction (IBA,IEA,TAS)

Cellular Component

membrane (IEA)

plasma membrane (IBA,IEA,TAS)

Molecular Function

G protein-coupled receptor activity (IEA)

olfactory receptor activity (IBA,IEA)

signaling receptor activity (TAS)

References

References - curated

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

Additional References at PubMed

PMID:8004088	PMID:8921386	PMID:9500546	PMID:10673334	PMID:12477932	PMID:14983052	PMID:15174051	PMID:21873635	PMID:23958962	PMID:32807901

Genomics

Comparative Map Data

OR3A2
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	17	3,276,113 - 3,386,308 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	17	3,276,177 - 3,386,317 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	17	3,179,407 - 3,289,602 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	17	3,127,934 - 3,129,018 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	17	3,128,013 - 3,236,337	NCBI
Celera	17	3,194,908 - 3,195,992 (-)	NCBI		Celera
Cytogenetic Map	17	p13.3	NCBI
HuRef	17	3,073,409 - 3,074,493 (-)	NCBI		HuRef
CHM1_1	17	3,190,075 - 3,191,159 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	17	3,164,339 - 3,275,247 (-)	NCBI		T2T-CHM13v2.0

Or3a1
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	11	74,225,108 - 74,226,055 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	11	74,221,107 - 74,228,857 (-)	Ensembl		GRCm39 Ensembl
GRCm38	11	74,334,282 - 74,335,229 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	11	74,330,281 - 74,338,031 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	11	74,147,784 - 74,148,731 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	11	74,150,477 - 74,151,424 (-)	NCBI		MGSCv36	mm8
Celera	11	81,843,103 - 81,844,050 (-)	NCBI		Celera
Cytogenetic Map	11	B5	NCBI
cM Map	11	45.76	NCBI

Or3a1e
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	10	59,521,798 - 59,522,745 (+)	NCBI		GRCr8
mRatBN7.2	10	59,023,353 - 59,024,300 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	10	59,023,353 - 59,024,300 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	10	63,650,376 - 63,651,323 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	10	63,155,979 - 63,156,926 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	10	58,650,565 - 58,651,512 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	10	60,997,525 - 60,998,472 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	10	60,997,525 - 60,998,472 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	10	60,731,039 - 60,731,890 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	10	61,444,058 - 61,445,005 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	10	61,457,680 - 61,458,628 (+)	NCBI
Celera	10	58,064,583 - 58,065,530 (+)	NCBI		Celera
Cytogenetic Map	10	q24	NCBI

OR3A2
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	9	47,191,669 - 47,192,628 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	9	47,191,669 - 47,192,634 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	9	46,344,261 - 46,345,208 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	9	48,027,439 - 48,028,386 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	9	48,027,439 - 48,028,404 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	9	46,791,074 - 46,792,018 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	9	47,085,326 - 47,086,273 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	9	47,140,952 - 47,141,899 (-)	NCBI		UU_Cfam_GSD_1.0

LOC100514488
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	12	49,379,227 - 49,380,174 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	12	49,378,101 - 49,381,018 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	12	51,337,721 - 51,338,807 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

Variants

Variants in OR3A2
49 total Variants

Clinical Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 17p13.3-13.2(chr17:2357067-4328426)x3	copy number gain	See cases [RCV000052456]	Chr17:2357067..4328426 [GRCh38] Chr17:2260361..4231721 [GRCh37] Chr17:2207111..4178470 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:193307-5652222)x1	copy number loss	See cases [RCV000053384]	Chr17:193307..5652222 [GRCh38] Chr17:45835..5555542 [GRCh37] Chr17:43098..5496266 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:198748-3436345)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053386]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053386]\|See cases [RCV000053386]	Chr17:198748..3436345 [GRCh38] Chr17:50690..3339639 [GRCh37] Chr17:48539..3286389 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:2527510-3467165)x1	copy number loss	See cases [RCV000053405]	Chr17:2527510..3467165 [GRCh38] Chr17:2430804..3370459 [GRCh37] Chr17:2377554..3317209 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:3036729-3684667)x3	copy number gain	See cases [RCV000053972]	Chr17:3036729..3684667 [GRCh38] Chr17:2940023..3587961 [GRCh37] Chr17:2886773..3534710 [NCBI36] Chr17:17p13.3-13.2	uncertain significance
GRCh38/hg38 17p13.3-13.2(chr17:3208843-3839780)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053973]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053973]\|See cases [RCV000053973]	Chr17:3208843..3839780 [GRCh38] Chr17:3112137..3743074 [GRCh37] Chr17:3058887..3689823 [NCBI36] Chr17:17p13.3-13.2	uncertain significance
NM_002551.3(OR3A2):c.913G>A (p.Asp305Asn)	single nucleotide variant	Malignant melanoma [RCV000071419]	Chr17:3278023 [GRCh38] Chr17:3181317 [GRCh37] Chr17:3128067 [NCBI36] Chr17:17p13.3	not provided
NM_002551.3(OR3A2):c.353G>A (p.Gly118Glu)	single nucleotide variant	Malignant melanoma [RCV000071420]	Chr17:3278583 [GRCh38] Chr17:3181877 [GRCh37] Chr17:3128627 [NCBI36] Chr17:17p13.3	not provided
NM_002551.3(OR3A2):c.339C>T (p.Phe113=)	single nucleotide variant	Malignant melanoma [RCV000071421]	Chr17:3278597 [GRCh38] Chr17:3181891 [GRCh37] Chr17:3128641 [NCBI36] Chr17:17p13.3	not provided
NM_002551.3(OR3A2):c.12G>A (p.Gln4=)	single nucleotide variant	Malignant melanoma [RCV000071422]	Chr17:3278924 [GRCh38] Chr17:3182218 [GRCh37] Chr17:3128968 [NCBI36] Chr17:17p13.3	not provided
NM_002551.3(OR3A2):c.596C>T (p.Ser199Phe)	single nucleotide variant	Malignant melanoma [RCV000063196]	Chr17:3278340 [GRCh38] Chr17:3181634 [GRCh37] Chr17:3128384 [NCBI36] Chr17:17p13.3	not provided
GRCh38/hg38 17p13.3-13.2(chr17:2062380-5258340)x1	copy number loss	See cases [RCV000133721]	Chr17:2062380..5258340 [GRCh38] Chr17:1965674..5161635 [GRCh37] Chr17:1912424..5102359 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.1(chr17:162088-6959050)x1	copy number loss	See cases [RCV000134135]	Chr17:162088..6959050 [GRCh38] Chr17:45835..6862369 [GRCh37] Chr17:11879..6803093 [NCBI36] Chr17:17p13.3-13.1	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:3155468-3543868)x1	copy number loss	See cases [RCV000133921]	Chr17:3155468..3543868 [GRCh38] Chr17:3058762..3447162 [GRCh37] Chr17:3005512..3393912 [NCBI36] Chr17:17p13.3-13.2	benign
GRCh38/hg38 17p13.3-13.1(chr17:198748-7491129)x3	copy number gain	See cases [RCV000134970]	Chr17:198748..7491129 [GRCh38] Chr17:50690..7394448 [GRCh37] Chr17:48539..7335172 [NCBI36] Chr17:17p13.3-13.1	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:226472-3655099)x1	copy number loss	See cases [RCV000135857]	Chr17:226472..3655099 [GRCh38] Chr17:396627..3558393 [GRCh37] Chr17:76263..3505142 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:1348488-3513273)x3	copy number gain	See cases [RCV000137603]	Chr17:1348488..3513273 [GRCh38] Chr17:1251782..3416567 [GRCh37] Chr17:1198532..3363317 [NCBI36] Chr17:17p13.3-13.2	likely pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:3102273-3667053)x3	copy number gain	See cases [RCV000137331]	Chr17:3102273..3667053 [GRCh38] Chr17:3005567..3570347 [GRCh37] Chr17:2952317..3517096 [NCBI36] Chr17:17p13.3-13.2	likely pathogenic\|uncertain significance
GRCh38/hg38 17p13.3-13.1(chr17:162016-7697012)x1	copy number loss	See cases [RCV000138214]	Chr17:162016..7697012 [GRCh38] Chr17:45835..7600330 [GRCh37] Chr17:11807..7541055 [NCBI36] Chr17:17p13.3-13.1	pathogenic
GRCh38/hg38 17p13.3-12(chr17:162016-12343901)x3	copy number gain	See cases [RCV000138531]	Chr17:162016..12343901 [GRCh38] Chr17:45835..12247218 [GRCh37] Chr17:11807..12187943 [NCBI36] Chr17:17p13.3-12	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:2062429-4141883)x3	copy number gain	See cases [RCV000139738]	Chr17:2062429..4141883 [GRCh38] Chr17:1965723..4045177 [GRCh37] Chr17:1912473..3991926 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:150732-5935377)x1	copy number loss	See cases [RCV000141658]	Chr17:150732..5935377 [GRCh38] Chr17:525..5838697 [GRCh37] Chr17:525..5779421 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:237248-4735533)x1	copy number loss	See cases [RCV000141559]	Chr17:237248..4735533 [GRCh38] Chr17:396627..4638828 [GRCh37] Chr17:87039..4585577 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:198748-4265640)x1	copy number loss	See cases [RCV000142440]	Chr17:198748..4265640 [GRCh38] Chr17:50690..4168935 [GRCh37] Chr17:48539..4115684 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:3168370-3862518)x3	copy number gain	See cases [RCV000142062]	Chr17:3168370..3862518 [GRCh38] Chr17:3071664..3765812 [GRCh37] Chr17:3018414..3712561 [NCBI36] Chr17:17p13.3-13.2	uncertain significance
GRCh38/hg38 17p13.3-12(chr17:150732-14764202)x3	copy number gain	See cases [RCV000142236]	Chr17:150732..14764202 [GRCh38] Chr17:525..14667519 [GRCh37] Chr17:525..14608244 [NCBI36] Chr17:17p13.3-12	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:2922729-3436438)x3	copy number gain	See cases [RCV000142895]	Chr17:2922729..3436438 [GRCh38] Chr17:2826023..3339732 [GRCh37] Chr17:2772773..3286482 [NCBI36] Chr17:17p13.3-13.2	pathogenic
GRCh38/hg38 17p13.3-13.2(chr17:3187406-3880628)x3	copy number gain	See cases [RCV000142793]	Chr17:3187406..3880628 [GRCh38] Chr17:3090700..3783922 [GRCh37] Chr17:3037450..3730671 [NCBI36] Chr17:17p13.3-13.2	uncertain significance
GRCh38/hg38 17p13.3-13.2(chr17:3168370-3852982)x3	copy number gain	See cases [RCV000143610]	Chr17:3168370..3852982 [GRCh38] Chr17:3071664..3756276 [GRCh37] Chr17:3018414..3703025 [NCBI36] Chr17:17p13.3-13.2	likely benign\|uncertain significance
GRCh37/hg19 17p13.3-13.2(chr17:919381-4046915)x3	copy number gain	See cases [RCV000240175]	Chr17:919381..4046915 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:1751557-5378509)x1	copy number loss	See cases [RCV000445994]	Chr17:1751557..5378509 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-13.1(chr17:1113102-6742486)	copy number gain	See cases [RCV000445679]	Chr17:1113102..6742486 [GRCh37] Chr17:17p13.3-13.1	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:48858-3379400)x1	copy number loss	See cases [RCV000448506]	Chr17:48858..3379400 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)	copy number gain	See cases [RCV000511439]	Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:525-3825428)x1	copy number loss	See cases [RCV000511508]	Chr17:525..3825428 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-12(chr17:525-15027737)x3	copy number gain	See cases [RCV000511786]	Chr17:525..15027737 [GRCh37] Chr17:17p13.3-12	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:1922768-3429136)x3	copy number gain	See cases [RCV000511855]	Chr17:1922768..3429136 [GRCh37] Chr17:17p13.3-13.2	likely pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:2339561-3447162)	copy number loss	Lissencephaly [RCV000626516]	Chr17:2339561..3447162 [GRCh37] Chr17:17p13.3-13.2	pathogenic
NM_002551.5(OR3A2):c.52C>G (p.Leu18Val)	single nucleotide variant	Inborn genetic diseases [RCV003262904]	Chr17:3278866 [GRCh38] Chr17:3182160 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.682G>A (p.Val228Ile)	single nucleotide variant	Inborn genetic diseases [RCV003245787]	Chr17:3278236 [GRCh38] Chr17:3181530 [GRCh37] Chr17:17p13.3	uncertain significance
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)x3	copy number gain	See cases [RCV000512441]	Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:525-4151421)x3	copy number gain	See cases [RCV000512413]	Chr17:525..4151421 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-12(chr17:525-11186432)x3	copy number gain	not provided [RCV000683866]	Chr17:525..11186432 [GRCh37] Chr17:17p13.3-12	pathogenic
GRCh37/hg19 17p13.3(chr17:2834635-3206175)x3	copy number gain	not provided [RCV000683877]	Chr17:2834635..3206175 [GRCh37] Chr17:17p13.3	likely benign
GRCh37/hg19 17p13.3-13.2(chr17:2944083-3429136)x3	copy number gain	not provided [RCV000683878]	Chr17:2944083..3429136 [GRCh37] Chr17:17p13.3-13.2	uncertain significance
GRCh37/hg19 17p13.3-q25.3(chr17:12344-81057996)x3	copy number gain	not provided [RCV000739325]	Chr17:12344..81057996 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:7214-81058310)x3	copy number gain	not provided [RCV000739320]	Chr17:7214..81058310 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:7214-3871323)x1	copy number loss	not provided [RCV000739319]	Chr17:7214..3871323 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:2050166-4315506)x1	copy number loss	not provided [RCV000751897]	Chr17:2050166..4315506 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:47546-6287620)	copy number gain	Chromosome 17P13.3, telomeric, duplication syndrome [RCV000767586]	Chr17:47546..6287620 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3(chr17:3039323-3237621)x1	copy number loss	not provided [RCV001007494]	Chr17:3039323..3237621 [GRCh37] Chr17:17p13.3	likely benign
GRCh37/hg19 17p13.3-13.2(chr17:8547-5627408)x1	copy number loss	See cases [RCV001007429]	Chr17:8547..5627408 [GRCh37] Chr17:17p13.3-13.2	pathogenic
NM_002550.3(OR3A1):c.524A>G (p.Asn175Ser)	single nucleotide variant	not provided [RCV000957508]	Chr17:3292059 [GRCh38] Chr17:3195353 [GRCh37] Chr17:17p13.3	benign
NM_002550.3(OR3A1):c.274A>T (p.Lys92Ter)	single nucleotide variant	not provided [RCV000957509]	Chr17:3292309 [GRCh38] Chr17:3195603 [GRCh37] Chr17:17p13.3	benign
NM_002550.3(OR3A1):c.541T>C (p.Tyr181His)	single nucleotide variant	not provided [RCV000957507]	Chr17:3292042 [GRCh38] Chr17:3195336 [GRCh37] Chr17:17p13.3	benign
GRCh37/hg19 17p13.3-13.2(chr17:3146183-3646235)x3	copy number gain	not provided [RCV001006859]	Chr17:3146183..3646235 [GRCh37] Chr17:17p13.3-13.2	likely benign
GRCh37/hg19 17p13.3(chr17:3057412-3228987)x1	copy number loss	not provided [RCV001006858]	Chr17:3057412..3228987 [GRCh37] Chr17:17p13.3	likely benign
GRCh37/hg19 17p13.3(chr17:2966291-3247171)x3	copy number gain	not provided [RCV001006857]	Chr17:2966291..3247171 [GRCh37] Chr17:17p13.3	likely benign
GRCh37/hg19 17p13.3-13.2(chr17:2313096-3735525)x1	copy number loss	not provided [RCV001537893]	Chr17:2313096..3735525 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:2646815-3698838)x3	copy number gain	not provided [RCV001834365]	Chr17:2646815..3698838 [GRCh37] Chr17:17p13.3-13.2	uncertain significance
GRCh37/hg19 17p13.3-13.2(chr17:2809266-3424183)x3	copy number gain	not provided [RCV001827915]	Chr17:2809266..3424183 [GRCh37] Chr17:17p13.3-13.2	uncertain significance
NC_000017.10:g.(?_2541583)_(3819519_?)del	deletion	not provided [RCV001901409]	Chr17:2541583..3819519 [GRCh37] Chr17:17p13.3-13.2	pathogenic
NC_000017.10:g.(?_1173858)_(3819519_?)dup	duplication	not provided [RCV002014058]	Chr17:1173858..3819519 [GRCh37] Chr17:17p13.3-13.2	uncertain significance
GRCh37/hg19 17p13.3-13.2(chr17:1095592-3484368)x3	copy number gain	not provided [RCV002472591]	Chr17:1095592..3484368 [GRCh37] Chr17:17p13.3-13.2	pathogenic
NM_002550.3(OR3A1):c.824A>G (p.Lys275Arg)	single nucleotide variant	Inborn genetic diseases [RCV002684710]	Chr17:3291759 [GRCh38] Chr17:3195053 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.413G>A (p.Arg138His)	single nucleotide variant	Inborn genetic diseases [RCV002682260]	Chr17:3278505 [GRCh38] Chr17:3181799 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.211G>C (p.Val71Leu)	single nucleotide variant	Inborn genetic diseases [RCV002883605]	Chr17:3278707 [GRCh38] Chr17:3182001 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.775A>G (p.Ile259Val)	single nucleotide variant	Inborn genetic diseases [RCV002762439]	Chr17:3278143 [GRCh38] Chr17:3181437 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.868C>G (p.Pro290Ala)	single nucleotide variant	Inborn genetic diseases [RCV002737387]	Chr17:3291715 [GRCh38] Chr17:3195009 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.391C>T (p.Arg131Trp)	single nucleotide variant	Inborn genetic diseases [RCV002761760]	Chr17:3292192 [GRCh38] Chr17:3195486 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.637C>T (p.Pro213Ser)	single nucleotide variant	Inborn genetic diseases [RCV002950471]	Chr17:3278281 [GRCh38] Chr17:3181575 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.707G>C (p.Gly236Ala)	single nucleotide variant	Inborn genetic diseases [RCV002704576]	Chr17:3278211 [GRCh38] Chr17:3181505 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.494C>T (p.Ala165Val)	single nucleotide variant	Inborn genetic diseases [RCV002926306]	Chr17:3278424 [GRCh38] Chr17:3181718 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.844A>G (p.Thr282Ala)	single nucleotide variant	Inborn genetic diseases [RCV002873579]	Chr17:3291739 [GRCh38] Chr17:3195033 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.802A>G (p.Thr268Ala)	single nucleotide variant	Inborn genetic diseases [RCV002708471]	Chr17:3291781 [GRCh38] Chr17:3195075 [GRCh37] Chr17:17p13.3	likely benign
NM_002550.3(OR3A1):c.833G>A (p.Gly278Glu)	single nucleotide variant	Inborn genetic diseases [RCV002854023]	Chr17:3291750 [GRCh38] Chr17:3195044 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.272G>A (p.Arg91His)	single nucleotide variant	Inborn genetic diseases [RCV002696969]	Chr17:3292311 [GRCh38] Chr17:3195605 [GRCh37] Chr17:17p13.3	likely benign
NM_002551.5(OR3A2):c.412C>T (p.Arg138Cys)	single nucleotide variant	Inborn genetic diseases [RCV002956316]	Chr17:3278506 [GRCh38] Chr17:3181800 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.868C>T (p.Pro290Ser)	single nucleotide variant	Inborn genetic diseases [RCV002893079]	Chr17:3278050 [GRCh38] Chr17:3181344 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.844A>G (p.Thr282Ala)	single nucleotide variant	Inborn genetic diseases [RCV002713368]	Chr17:3278074 [GRCh38] Chr17:3181368 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.473A>G (p.Asn158Ser)	single nucleotide variant	Inborn genetic diseases [RCV002697267]	Chr17:3292110 [GRCh38] Chr17:3195404 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.533A>G (p.Asn178Ser)	single nucleotide variant	Inborn genetic diseases [RCV003003777]	Chr17:3292050 [GRCh38] Chr17:3195344 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.271C>T (p.Arg91Cys)	single nucleotide variant	Inborn genetic diseases [RCV002698083]	Chr17:3292312 [GRCh38] Chr17:3195606 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.385A>G (p.Ile129Val)	single nucleotide variant	Inborn genetic diseases [RCV002709365]	Chr17:3278533 [GRCh38] Chr17:3181827 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.825A>C (p.Lys275Asn)	single nucleotide variant	Inborn genetic diseases [RCV002674704]	Chr17:3291758 [GRCh38] Chr17:3195052 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.49C>G (p.Leu17Val)	single nucleotide variant	Inborn genetic diseases [RCV002670517]	Chr17:3292534 [GRCh38] Chr17:3195828 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.816C>A (p.Asp272Glu)	single nucleotide variant	Inborn genetic diseases [RCV002808639]	Chr17:3291767 [GRCh38] Chr17:3195061 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.124G>T (p.Val42Phe)	single nucleotide variant	Inborn genetic diseases [RCV002920971]	Chr17:3292459 [GRCh38] Chr17:3195753 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.278G>T (p.Arg93Leu)	single nucleotide variant	Inborn genetic diseases [RCV002679476]	Chr17:3292305 [GRCh38] Chr17:3195599 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.809C>G (p.Ala270Gly)	single nucleotide variant	Inborn genetic diseases [RCV002679468]	Chr17:3278109 [GRCh38] Chr17:3181403 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.134A>C (p.Asn45Thr)	single nucleotide variant	Inborn genetic diseases [RCV002814224]	Chr17:3278784 [GRCh38] Chr17:3182078 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.280G>T (p.Ala94Ser)	single nucleotide variant	Inborn genetic diseases [RCV002679477]	Chr17:3292303 [GRCh38] Chr17:3195597 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.503C>T (p.Thr168Met)	single nucleotide variant	Inborn genetic diseases [RCV003188685]	Chr17:3278415 [GRCh38] Chr17:3181709 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.844A>T (p.Thr282Ser)	single nucleotide variant	Inborn genetic diseases [RCV003205750]	Chr17:3291739 [GRCh38] Chr17:3195033 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.829G>T (p.Val277Phe)	single nucleotide variant	Inborn genetic diseases [RCV003216857]	Chr17:3291754 [GRCh38] Chr17:3195048 [GRCh37] Chr17:17p13.3	uncertain significance
GRCh38/hg38 17p13.3-12(chr17:165730-11404096)x3	copy number gain	Chromosome 17p13.3 duplication syndrome [RCV003327726]	Chr17:165730..11404096 [GRCh38] Chr17:17p13.3-12	pathogenic
NM_002551.5(OR3A2):c.500C>T (p.Ser167Phe)	single nucleotide variant	Inborn genetic diseases [RCV003349685]	Chr17:3278418 [GRCh38] Chr17:3181712 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002551.5(OR3A2):c.748G>A (p.Val250Met)	single nucleotide variant	Inborn genetic diseases [RCV003356296]	Chr17:3278170 [GRCh38] Chr17:3181464 [GRCh37] Chr17:17p13.3	uncertain significance
GRCh37/hg19 17p13.3-13.2(chr17:526-3441645)x1	copy number loss	not provided [RCV003483307]	Chr17:526..3441645 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:2433587-3484368)x1	copy number loss	not provided [RCV003483311]	Chr17:2433587..3484368 [GRCh37] Chr17:17p13.3-13.2	pathogenic
Single allele	deletion	not provided [RCV003448682]	Chr17:2..4611147 [GRCh37] Chr17:17p13.3-13.2	pathogenic
NM_002550.3(OR3A1):c.100T>A (p.Phe34Ile)	single nucleotide variant	not provided [RCV003428056]	Chr17:3292483 [GRCh38] Chr17:3195777 [GRCh37] Chr17:17p13.3	likely benign
NM_002550.3(OR3A1):c.465T>C (p.Ala155=)	single nucleotide variant	not provided [RCV003419569]	Chr17:3292118 [GRCh38] Chr17:3195412 [GRCh37] Chr17:17p13.3	likely benign
GRCh37/hg19 17p13.3-13.2(chr17:9474-6017500)x1	copy number loss	not specified [RCV003987214]	Chr17:9474..6017500 [GRCh37] Chr17:17p13.3-13.2	pathogenic
GRCh37/hg19 17p13.3-11.2(chr17:525-21510992)x3	copy number gain	not specified [RCV003987215]	Chr17:525..21510992 [GRCh37] Chr17:17p13.3-11.2	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:2674657-3484368)x3	copy number gain	not specified [RCV003987223]	Chr17:2674657..3484368 [GRCh37] Chr17:17p13.3-13.2	uncertain significance
NM_002550.3(OR3A1):c.356C>T (p.Thr119Ile)	single nucleotide variant	Inborn genetic diseases [RCV003357303]	Chr17:3292227 [GRCh38] Chr17:3195521 [GRCh37] Chr17:17p13.3	uncertain significance
GRCh37/hg19 17p13.3-q25.3(chr17:8547-81060040)x3	copy number gain	not provided [RCV000739324]	Chr17:8547..81060040 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-13.2(chr17:3160211-3424544)x3	copy number gain	not provided [RCV000846629]	Chr17:3160211..3424544 [GRCh37] Chr17:17p13.3-13.2	uncertain significance
NM_002550.3(OR3A1):c.564C>G (p.Phe188Leu)	single nucleotide variant	Inborn genetic diseases [RCV002752878]	Chr17:3292019 [GRCh38] Chr17:3195313 [GRCh37] Chr17:17p13.3	uncertain significance
NM_002550.3(OR3A1):c.437T>C (p.Met146Thr)	single nucleotide variant	Inborn genetic diseases [RCV003215523]	Chr17:3292146 [GRCh38] Chr17:3195440 [GRCh37] Chr17:17p13.3	uncertain significance

miRNA Target Status

Predicted Target Of

	Summary Value
Count of predictions:	254
Count of miRNA genes:	246
Interacting mature miRNAs:	254
Transcripts:	ENST00000408891
Prediction methods:	Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region

OR3A2__7150

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	3,181,162 - 3,181,937	UniSTS	GRCh37
Build 36	17	3,127,912 - 3,128,687	RGD	NCBI36
Celera	17	3,194,886 - 3,195,661	RGD
HuRef	17	3,073,387 - 3,074,162	UniSTS

Expression

RNA-SEQ Expression

High: > 1000 TPM value Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system

circulatory system

endocrine system

exocrine system

hemolymphoid system

hepatobiliary system

integumental system

musculoskeletal system

nervous system

renal system

reproductive system

respiratory system

sensory system

adipose tissue

appendage

entire extraembryonic component

High

Medium

Low

102

356

446

Below cutoff

945

854

642

113

586

1353

710

2420

146

394

568

599

845

View RNA-SEQ Expression Data

Sequence

Nucleotide Sequences


RefSeq Transcripts	NM_002551	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017024697	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017024698	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047436157	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054316288	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC087498	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF087930	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC095517	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BK004239	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471108	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068261	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KP290345	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U04713	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U86244	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

RefSeq Acc Id:

ENST00000408891 ⟹ ENSP00000386180

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	3,277,899 - 3,278,974 (-)	Ensembl

RefSeq Acc Id:

ENST00000573491 ⟹ ENSP00000493118

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	3,278,775 - 3,386,293 (-)	Ensembl

RefSeq Acc Id:

ENST00000573901

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	3,276,177 - 3,386,308 (-)	Ensembl

RefSeq Acc Id:

ENST00000576166 ⟹ ENSP00000493095

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	3,278,826 - 3,386,317 (-)	Ensembl

RefSeq Acc Id:

ENST00000641164 ⟹ ENSP00000493039

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	3,276,942 - 3,278,974 (-)	Ensembl

RefSeq Acc Id:

ENST00000642052 ⟹ ENSP00000493441

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	3,277,199 - 3,284,380 (-)	Ensembl

RefSeq Acc Id:

NM_002551 ⟹ NP_002542

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	3,276,177 - 3,386,308 (-)	NCBI
GRCh37	17	3,181,184 - 3,182,268 (-)	RGD
Build 36	17	3,127,934 - 3,129,018 (-)	NCBI Archive
Celera	17	3,194,908 - 3,195,992 (-)	RGD
HuRef	17	3,073,409 - 3,074,493 (-)	RGD
CHM1_1	17	3,190,075 - 3,191,159 (-)	NCBI
T2T-CHM13v2.0	17	3,164,403 - 3,275,247 (-)	NCBI

Sequence:

show sequence

ACGCCGCCGTCGGGCGGTCGTAGGACATGGCCGCCAGGAGGTAGCTCTCGGTGATGCCCAGAGC
CACGAAGAAGTACATCTCGGCAAAGCACGCCTGGAAGGATATGGCCTGGCCCGGGTGGAGCAGG
CCGGCCAGCAGCCTGGGGACCGTGACGGTGGTAAAGCAGACGTCCACGAGGCTCAGACATGCCA
CAAAATGTTGAATGAAGATAGGCAGCGTTGGCAAGGAGAGTTTCTGAAACTTCCACTGGAGGGC
TCTGCGTGTTCCGGCAGGAATGGTTTGAGAGCCAGTTTCTGAGTGCCCCAGAGGAGAATGCTGT
AGTGAACACAGCCCTGTACAGAGAAGACAGCAGCTTGATTCCTCTCATTTCTCAGTCATTAGCC
CCTCACTCGCTCTCCGGGAGGATAACGGGGTGTGCGCAGCTCCTCCCCTTCTTTCCTGAAGAAA
CCTCAGTGGCTTCCGTGCCCTTGCCAGGGTATTCTGACCTTTTCAGCTAGCAGAGGATGAGGAG
GACAAGGTGGTGGTGTCATTGGGCATGTCAACCAAGAGCAAGAAACTCATGGAGCCAGAAGCTG
GGACCAATAGGACCGCTGTTGCTGAGTTCATTCTACTGGGCCTAGTGCAAACAGAAGAGATGCA
GCCAGTTGTCTTTGTGCTCCTCCTCTTTGCCTATCTGGTCACAACTGGGGGCAACCTCAGCATC
CTGGCAGCCGTCTTGGTGGAGCCCAAACTCCACGCCCCCATGTACTTCTTCCTGGGGAACCTGT
CAGTGCTGGATGTCGGATGTATCACTGTCACTGTTCCTGCAATGTTGGGTCGTCTCTTGTCCCA
CAAGTCCACAATTTCCTATGACGCCTGCCTCTCCCAGCTCTTCTTCTTCCACCTTCTGGCTGGG
ATGGACTGCTTCCTGCTGACCGCCATGGCCTATGACCGACTCCTGGCCATCTGCCAGCCCCTCA
CCTACAGCACCCGCATGAGTCAGACAGTCCAGAGGATGTTGGTGGCTGCGTCCTTGGCTTGTGC
CTTCACCAACGCACTGACCCACACTGTGGCCATGTCCACGCTCAACTTCTGTGGCCCCAATGAG
GTCAATCACTTCTACTGTGACCTCCCACAGCTCTTCCAGCTCTCCTGCTCCAGCACCCAACTCA
ATGAGCTGCTGCTCTTTGCTGTGGGTTTCATCATGGCAGGCACACCTTTGGTTCTCATCATCAC
TGCCTACAGCCACGTGGCAGCTGCAGTTCTACGAATCCGTTCAGTGGAGGGCCGAAAGAAGGCC
TTCTCCACGTGTGGCTCCCACCTCACCGTGGTTTGTCTTTTCTTTGGAAGAGGTATCTTCAACT
ACATGAGACTGGGTTCAGAGGAGGCTTCAGACAAGGATAAAGGGGTTGGAGTTTTCAACACTGT
TATCAACCCTATGCTGAACCCTCTTATCTACAGCCTCAGAAACCCTGATGTTCAGGGTGCTCTG
TGGCAAATATTTTTGGGGAGGAGATCACTGACCTGAGAGGTAATGGGGTCCCTCCTTTCCTGCC
TTTTCTGGACTGAGGAAAATTTCCCATGAAGACAGTAACCAGGAAAAATTCAGCCACAACTATT
TTTCCTATCTCCTGATGCTTGAAGATCGGTGTTACATATTTGTCCTACTAGGAAACCCTACATA
ATTTATTCATTCAACAAATACTTATTAGAGTACCTCTATGATCTGGACAGTCTTCCAAGGCATT
GGTGGACAAAATGGACAAAAGTCTCTGCACTCATGCAACTCACATGCTATAAAAGTAGACAAAG
TAAATAAGCATCATATATACCACATGATGATAGTTTCTATAGAGATGAACAAAGATGTTAATAT
GAAGTCAGGTTCTGCCAAGCAAGCCCTGTGCAAGTTTTACCCTGTTTTTGGCTGTGCCTACTTT
CTGGATAGAGTTAAAGCCTTGTAGTTCTGTGTGCCTGGCAAGCAGCATTCTACAAAGAATGTCC
AGTCGGTCAATCACAGCCTAAGTGACCAAAAGTATTTCTGCAATATTTCTGGTGAGGACATGAG
ATTCCCTGCAGATCAGAATAGGGGAAAATTTTTTGTTTGTTTCTTTGTTTTGTTTTGTTGTTGT
TTTGTTAAAAACTTGTTAAAAAGTTTTTTAAAAAAACCAAAACCATAGGCCTAGTGCAATGGAT
TATTTCATTCATTTGTTTGCCTTTCACCTTCATTTTCTTCTCTCCGCTACCACAAAAGAATCCT
GCTGGATGTTGACTGGGCGCAGGGTGGCTGACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGG
CGGATGGATCACGAGGTCAGGAGATCGAGACCATCCTGACTAACATAGTGAAACCCCTTCTCTA
CTATAAATACAAAAACAAAATTAGCCGGTGTAGTGGTGGGCGCCTGTAGTCCCAGCTACTCGGG
AGGCTGAGGCAGGAGAATGGCGTGAACCTGGGGGGCGGAGCTTGCAGTGAGCCGAGATAGCGCC
ACTGCACTCCAGCCTGGGCGACAGAGCAAGACTCCGTCTCAAAAAAAAAAAAAAAAAGAATCCT
GCTGGATGTTTAGGGAACAGGAAAGGTCTAGAGAGGAAAAGAGCCCACTAAATTAAAACTACGT
TCATACATATATGATATATCTTAAGGTCATAAAAGGAAGGTTTCATCTCCATTCCCTGCCATGC
CTTTTTCTCTCATTTAATGTTACCTTCCTCACACATATGATAAAGTTTTTGAAAGAGTAAATGT
TTGTATTACAATCAGGTCCTTAGAATTTTCAATGTAGAATATCCAATATAACCTTCTCCTCCAA
AGTCTTACTTAGCTCTCTCAAAGCTCCTTGCTTAGAAAATACATACCCATAAATGTAGTTCCTG
GAAAGGAGGGATGCATGCATGCCTGTCTTCCTTCCTTCCCAGTGTAAATATATTTATTTTAAAA
ATTATTCAGAATGTTATACCTAATAGTGGAAACATTCAGACGATATTATTTTGTCAAGTAGGAA
ATAAAAATCCAAATGTTCCTTCACTGCACCAAAAATCACACTGTTCAGAGTTTACGCCTCTGAC
AATTGTTGTGTTTTTTCCTCTAGCGATTTCCTGTATATATGATATGCCCGTTTCACATCAGTAG
AACCATACTGTTCTGTGATCTGCTTCCTGTTTTTCCTGCATATTGTGCCATACAATCTTTTACA
TAATGAAGACTAACATCCTGCTTTATCTGTTTTAATGGTGGCACAGTATATCATTAAACATGTA
AGTCACAATTTCTTTCATTAAACCTCTATTTCTATAATTTGGGTTATTTTCAATTGTTTTGCAA
CAACAATGTTGTGATGAATATTCTTTTTTTTTTCTTT

hide sequence

RefSeq Acc Id:

XM_047436157 ⟹ XP_047292113

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	3,276,113 - 3,386,308 (-)	NCBI

RefSeq Acc Id:

XM_054316288 ⟹ XP_054172263

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	17	3,164,339 - 3,187,686 (-)	NCBI

Protein Sequences


Protein RefSeqs	NP_002542	(Get FASTA)	NCBI Sequence Viewer
	XP_047292113	(Get FASTA)	NCBI Sequence Viewer
	XP_054172263	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAA17448	(Get FASTA)	NCBI Sequence Viewer
	AAC39624	(Get FASTA)	NCBI Sequence Viewer
	AAF37318	(Get FASTA)	NCBI Sequence Viewer
	AAH95517	(Get FASTA)	NCBI Sequence Viewer
	ALI87521	(Get FASTA)	NCBI Sequence Viewer
	DAA04637	(Get FASTA)	NCBI Sequence Viewer
	EAW90516	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000493039.1
	ENSP00000493095.1
	ENSP00000493118.1
	ENSP00000493441.1
	ENSP00000516654
	ENSP00000516654.1
GenBank Protein	P47893	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_002542 ⟸ NM_002551

- UniProtKB:

Q9P1Q3 (UniProtKB/Swiss-Prot), Q6IFM3 (UniProtKB/Swiss-Prot), P47893 (UniProtKB/Swiss-Prot), A0A286YFF0 (UniProtKB/TrEMBL), A0A126GVQ3 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MSLQKLMEPEAGTNRTAVAEFILLGLVQTEEMQPVVFVLLLFAYLVTTGGNLSILAAVLVEPKL
HAPMYFFLGNLSVLDVGCITVTVPAMLGRLLSHKSTISYDACLSQLFFFHLLAGMDCFLLTAMA
YDRLLAICQPLTYSTRMSQTVQRMLVAASLACAFTNALTHTVAMSTLNFCGPNEVNHFYCDLPQ
LFQLSCSSTQLNELLLFAVGFIMAGTPLVLIITAYSHVAAAVLRIRSVEGRKKAFSTCGSHLTV
VCLFFGRGIFNYMRLGSEEASDKDKGVGVFNTVINPMLNPLIYSLRNPDVQGALWQIFLGRRSL
T

hide sequence

RefSeq Acc Id:

ENSP00000493118 ⟸ ENST00000573491

RefSeq Acc Id:

ENSP00000493095 ⟸ ENST00000576166

RefSeq Acc Id:

ENSP00000493039 ⟸ ENST00000641164

RefSeq Acc Id:

ENSP00000493441 ⟸ ENST00000642052

RefSeq Acc Id:

ENSP00000386180 ⟸ ENST00000408891

RefSeq Acc Id:	XP_047292113 ⟸ XM_047436157
- Peptide Label:	isoform X1
- UniProtKB:	Q9P1Q3 (UniProtKB/Swiss-Prot), Q6IFM3 (UniProtKB/Swiss-Prot), P47893 (UniProtKB/Swiss-Prot), A0A126GVQ3 (UniProtKB/TrEMBL)

RefSeq Acc Id:	XP_054172263 ⟸ XM_054316288
- Peptide Label:	isoform X1
- UniProtKB:	Q9P1Q3 (UniProtKB/Swiss-Prot), Q6IFM3 (UniProtKB/Swiss-Prot), P47893 (UniProtKB/Swiss-Prot), A0A126GVQ3 (UniProtKB/TrEMBL)

Protein Domains

G-protein coupled receptors family 1 profile

Protein Structures

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-P47893-F1-model_v2	AlphaFold	P47893	1-321	view protein structure

Additional Information

External Database Links

Database	Acc Id	Source(s)
AGR Gene	HGNC:8283	AgrOrtholog
COSMIC	OR3A2	COSMIC
Ensembl Genes	ENSG00000221882	Ensembl, ENTREZGENE, UniProtKB/TrEMBL
Ensembl Transcript	ENST00000573491.5	UniProtKB/TrEMBL
	ENST00000573901	ENTREZGENE
	ENST00000573901.3	UniProtKB/TrEMBL
	ENST00000576166.2	UniProtKB/TrEMBL
	ENST00000641164.1	UniProtKB/TrEMBL
	ENST00000642052.1	UniProtKB/TrEMBL
Gene3D-CATH	Rhodopsin 7-helix transmembrane proteins	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx	ENSG00000221882	GTEx
HGNC ID	HGNC:8283	ENTREZGENE
Human Proteome Map	OR3A2	Human Proteome Map
InterPro	GPCR_Rhodpsn	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
	GPCR_Rhodpsn_7TM	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
	Olfact_rcpt	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report	hsa:4995	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
NCBI Gene	4995	ENTREZGENE
PANTHER	OLFACTORY RECEPTOR	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
	OLFACTORY RECEPTOR 3A2	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam	7tm_4	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB	PA32224	PharmGKB
PRINTS	GPCRRHODOPSN	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
	OLFACTORYR	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE	G_PROTEIN_RECEP_F1_2	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP	Family A G protein-coupled receptor-like	UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt	A0A126GVQ3	ENTREZGENE, UniProtKB/TrEMBL
	A0A286YF44_HUMAN	UniProtKB/TrEMBL
	A0A286YF70_HUMAN	UniProtKB/TrEMBL
	A0A286YFF0	ENTREZGENE, UniProtKB/TrEMBL
	OR3A2_HUMAN	UniProtKB/Swiss-Prot, ENTREZGENE
	Q6IFM3	ENTREZGENE
	Q9P1Q3	ENTREZGENE
UniProt Secondary	Q6IFM3	UniProtKB/Swiss-Prot
	Q9P1Q3	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-12-15	OR3A2	olfactory receptor family 3 subfamily A member 2	OR3A2	olfactory receptor, family 3, subfamily A, member 2	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable
Gene Annotator (Functional Annotation)	Gene Annotator (Annotation Distribution)	Variant Visualizer (Genomic Variants)

InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable
InterViewer (Protein-Protein Interactions)	GViewer (Genome Viewer)	Variant Visualizer (Damaging Variants)

Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
Gene Annotator (Annotation Comparison)	OLGA (Gene List Generator)	Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable
MOET (Multi-Ontology Enrichement)	GOLF (Gene-Ortholog Location Finder)

Send us a Message

Imported Disease Annotations - ClinVar